Collagenase Clostridium Histolyticum

CHEMBL2108709 Phase 4 ได้รับการอนุมัติ Enzyme
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

An injectable enzyme derived from the bacterium Clostridium histolyticum, used to break down the abnormal collagen cords that cause Dupuytren's contracture, a condition causing fingers to bend permanently toward the palm. It is also approved for treating Peyronie's disease, a condition involving scar tissue in the penis causing painful curved erections. Injection into the abnormal tissue allows for mechanical straightening of the affected area afterward.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

An injectable enzyme derived from the bacterium Clostridium histolyticum, used to break down the abnormal collagen cords that cause Dupuytren's contracture, a condition causing fingers to bend permanently toward the palm. It is also approved for treating Peyronie's disease, a condition involving scar tissue in the penis causing painful curved erections. Injection into the abnormal tissue allows for mechanical straightening of the affected area afterward.

Yes, Collagenase Clostridium Histolyticum is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108709. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.